Tawanda Gumbo

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 25

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

American journal of respiratory and critical care medicine

Open forum infectious diseases

Baylor Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Baylor Research Institute

United States

Director :: Baylor Institute for Immunology Research

Publications

Ronald G Hall, Shuhan Liu, William C Putnam, Rajareddy Kallem, Tawanda Gumbo, Manjunath Amit P Pai
Optimizing anidulafungin exposure across a wide adult body size range. Antimicrobial agents and chemotherapy (2023)
Devyani Deshpande, Gesham Magombedze, Gunavanthi D Boorgula, Moti Chapagain, Shashikant Srivastava, Tawanda Gumbo
Ceftriaxone efficacy for Mycobacterium avium complex lung disease in the hollow fiber and translation to sustained sputum culture conversion in patients. The Journal of infectious diseases (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Shashikant Srivastava, Tawanda Gumbo
Comment on "Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections". Open forum infectious diseases 10 (8) (2023)
Tawanda Gumbo, Shashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, Alexander Berg, Klaus Romero, David Hermann, Debra Hanna
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development. The Journal of antimicrobial chemotherapy (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Yongge Liu, Mischka Moodley, Jotam G Pasipanodya, Tawanda Gumbo
Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments. Antimicrobial agents and chemotherapy (2023)
Sanjay Singh, Gunavanthi D Boorgula, Santosh Aryal, Julie V Philley, Tawanda Gumbo, Shashikant Srivastava
Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far. The Journal of antimicrobial chemotherapy (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Tania A Thomas, Julie V Philley, Shashikant Srivastava
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial agents and chemotherapy 68 (2) (2023)
Swati Patel, Moti Chapagain, Clifford Mason, Matthew Gingrich, Shruti Athale, Wendy Ribble, Teresa Hoang, Joshua Day, Xicheng Sun, Thale Jarvis, Urs A Ochsner, David Howe, Tawanda Gumbo
Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Kamunkhwala Gausi, Maxwell Tawanda Chirehwa, Elisa H Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L Rosenkranz, Veronique de Jager, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Susan Swindells, Andreas Diacon, Kelly E Dooley, Helen McIlleron, Paolo Denti
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Jotam G Pasipanodya, Tawanda Gumbo
The Relationship Between Drug Concentration in Tuberculosis Lesions, Epithelial Lining Fluid, and Clinical Outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (9) (2021)
Gesham Magombedze, Jotam G Pasipanodya, Tawanda Gumbo
Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse. Communications biology 4 (1) (2021)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy 65 (10) (2021)
Shashikant Srivastava, Jann-Yuan Wang, Gesham Magombedze, Moti Chapagain, Hung-Ling Huang, Devyani Deshpande, Scott K Heysell, Jotam G Pasipanodya, Tawanda Gumbo
Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii. Antimicrobial agents and chemotherapy (2021)
Keertan Dheda, Laura Lenders, Shashikant Srivastava, Gesham Magombedze, Helen Wainwright, Prithvi Raj, Stephen J Bush, Gabriele Pollara, Rachelle Steyn, Malika Davids, Anil Pooran, Timothy Pennel, Anthony Linegar, Ruth McNerney, Loven Moodley, Jotam G Pasipanodya, Carolin T Turner, Mahdad Noursadeghi, Robin M Warren, Edward Wakeland, Tawanda Gumbo
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing. American journal of respiratory and critical care medicine 200 (3) (2020)
Suresh Mallikaarjun, Moti L Chapagain, Tomohiro Sasaki, Norimitsu Hariguchi, Devyani Deshpande, Shashikant Srivastava, Alexander Berg, Kuniko Hirota, Yusuke Inoue, Makoto Matsumoto, Jeffrey Hafkin, Lawrence Geiter, Xiaofeng Wang, Tawanda Gumbo, Yongge Liu
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 65 (1) (2020)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone. Antimicrobial agents and chemotherapy 64 (11) (2020)
Moti Chapagain, Tawanda Gumbo, Scott K Heysell, Shashikant Srivastava
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii. Antimicrobial agents and chemotherapy 64 (10) (2020)
Keertan Dheda, Laura Lenders, Gesham Magombedze, Shashikant Srivastava, Prithvi Raj, Erland Arning, Paula Ashcraft, Teodoro Bottiglieri, Helen Wainwright, Timothy Pennel, Anthony Linegar, Loven Moodley, Anil Pooran, Jotam G Pasipanodya, Frederick A Sirgel, Paul D van Helden, Edward Wakeland, Robin M Warren, Tawanda Gumbo
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis. American journal of respiratory and critical care medicine 198 (9) (2019)

Tawanda Gumbo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tawanda Gumbo